Inducible Lentivirus‐Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2015 (1) , 523896
Abstract
Although bone cancer pain is still not fully understood by scientists and clinicians alike, studies suggest that toll like receptor 4 (TLR4) plays an important role in the initiation and/or maintenance of pathological pain state in bone cancer pain. A promising treatment for bone cancer pain is the downregulation of TLR4 by RNA interference; however, naked siRNA (small interference RNA) is not effective in long‐term treatments. In order to concoct a viable prolonged treatment for bone cancer pain, an inducible lentivirus LvOn‐siTLR4 (tetracycline inducible lentivirus carrying siRNA targeting TLR4) was prepared and the antinociception effects were observed in bone cancer pain rats induced by Walker 256 cells injection in left leg. Results showed that LvOn‐siTLR4 intrathecal injection with doxycycline (Dox) oral administration effectively reduced the nociception induced by Walker 256 cells while inhibiting the mRNA and protein expression of TLR4. Proinflammatory cytokines as TNF‐α and IL‐1β in spinal cord were also decreased. These findings suggest that TLR4 could be a target for bone cancer pain treatment and tetracycline inducible lentivirus LvOn‐siTLR4 represents a new potential option for long‐term treatment of bone cancer pain.Keywords
Funding Information
- National Natural Science Foundation of China (30901403)
This publication has 37 references indexed in Scilit:
- Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injuryJournal of Neuroinflammation, 2013
- Small Interference RNA Targeting TLR4 Gene Effectively Attenuates Pulmonary Inflammation in a Rat ModelJournal of Biomedicine and Biotechnology, 2012
- Inhibition of TLR4-Induced IκB Kinase Activity by the RON Receptor Tyrosine Kinase and Its Ligand, Macrophage-Stimulating ProteinThe Journal of Immunology, 2010
- Tetracycline‐regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defectsArthritis & Rheumatism, 2010
- Bilateral downregulation of Nav1.8 in dorsal root ganglia of rats with bone cancer pain induced by inoculation with Walker 256 breast tumor cellsBMC Cancer, 2010
- Down-Regulation of Toll-Like Receptor 4 Gene Expression by Short Interfering RNA Attenuates Bone Cancer Pain in a Rat ModelMolecular Pain, 2010
- Lentiviral vectors for gene transfer into the spinal cord glial cellsGene Therapy, 2009
- Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in miceGlia, 2008
- Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4)European Journal of Neuroscience, 2008
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976